ATXN2 and amyotrophic lateral sclerosis: None of the 15 ALS patients, carrying various mutations in different ALS disease genes (SOD1, FUS, UBQLN2, OPTN, SPG11 and PLEKHG5) showed expansions in ATXN2 (p = 0.78) (Table S1).